 |
| Glycodal - M |
Glycodal - M Suspension Composition
Each 100 ml contains:
Magaldrate 9.6 gm
Pharmacodynamics
Magaldrate is an aluminum, magnesium hydroxide. Aluminum hydroxide, given by mouth slowly reacts with the hydrochloric acid in the stomach to form soluble aluminum chloride Pharmacokinetics
* About 0.1 to 0.5mg of the cation is reported to be absorbed from standard daily doses of an aluminum - contaniing antacid
Absorbed aluminum is eliminated in the urine
Indications
As an antacid for symptomatic relief of hyperacidity associated with the diagnosis of peptic ulcer gastritis peptic esophagitis. gasiric hyperacidity heartbum and hiatal hernia.
Patient information
Do not take more than 16 teaspoonfuls in a 24 hours period or use the maximum dosage for more than 2 weeks or use if you have kidney disease except under the advice and supervision of a physician, keep this drug Out of the reach of children
Warnings:
Prolonged use of aluminum - containing antacids in patients with renal failure may result in or worsen dialysis osteomalacia. Elevated tissue aluminum levels contribute to the development of the dialysis encephalopathy and osteomalacia syndromes Small amounts of aluminum are absorbed from the gastrointestinal tract and renal excretion of aluminum is impaired in renal failure Aluminum is not well removed by dialysis because it is bound to albumin and transferrin, which do not cross dialysis membranes. As a result aluminum is deposited in bone and dialysis osteomalacia may develop when large anounts of aluminum are ingested orally by patients with impaired renal function . Aluminum forms insoluble complexes with phosphate in the gastrointestinal tract . Prolonged use of aluminum containing antacids by normophosphafemic patients may result in hypophosphatemia if phosphate intake is not adequate. In its more severe forms, hypophosphatemia can lead to anorexia, malaise, muscle weakness , and osteomalacia.
Drug Interaction:
Antacids may interaci with certain prescription drugs . If you are presently taking a prescription drug, do not take this product without checking with your physician or other health professfonal.
Dose:
Two to four teaspoonfuls, four times a day or as directed by a physician.
Package:
Carton box contains bottle . of 100 ml, 200 ml, or 300 ml suspension
ALEXANDRIA Co. FOR PHARMACEUTICALS
ALEXANORtA - EGYPT
Each 100 ml contains:
Magaldrate 9.6 gm
Pharmacodynamics
Magaldrate is an aluminum, magnesium hydroxide. Aluminum hydroxide, given by mouth slowly reacts with the hydrochloric acid in the stomach to form soluble aluminum chloride Pharmacokinetics
* About 0.1 to 0.5mg of the cation is reported to be absorbed from standard daily doses of an aluminum - contaniing antacid
Absorbed aluminum is eliminated in the urine
Indications
As an antacid for symptomatic relief of hyperacidity associated with the diagnosis of peptic ulcer gastritis peptic esophagitis. gasiric hyperacidity heartbum and hiatal hernia.
Patient information
Do not take more than 16 teaspoonfuls in a 24 hours period or use the maximum dosage for more than 2 weeks or use if you have kidney disease except under the advice and supervision of a physician, keep this drug Out of the reach of children
Warnings:
Prolonged use of aluminum - containing antacids in patients with renal failure may result in or worsen dialysis osteomalacia. Elevated tissue aluminum levels contribute to the development of the dialysis encephalopathy and osteomalacia syndromes Small amounts of aluminum are absorbed from the gastrointestinal tract and renal excretion of aluminum is impaired in renal failure Aluminum is not well removed by dialysis because it is bound to albumin and transferrin, which do not cross dialysis membranes. As a result aluminum is deposited in bone and dialysis osteomalacia may develop when large anounts of aluminum are ingested orally by patients with impaired renal function . Aluminum forms insoluble complexes with phosphate in the gastrointestinal tract . Prolonged use of aluminum containing antacids by normophosphafemic patients may result in hypophosphatemia if phosphate intake is not adequate. In its more severe forms, hypophosphatemia can lead to anorexia, malaise, muscle weakness , and osteomalacia.
Drug Interaction:
Antacids may interaci with certain prescription drugs . If you are presently taking a prescription drug, do not take this product without checking with your physician or other health professfonal.
Dose:
Two to four teaspoonfuls, four times a day or as directed by a physician.
Package:
Carton box contains bottle . of 100 ml, 200 ml, or 300 ml suspension
ALEXANDRIA Co. FOR PHARMACEUTICALS
ALEXANORtA - EGYPT
No comments:
Post a Comment